# Immunophenotypage of RIF and RM Patients and Intrauterine Administration of PBMC

> **NCT04753736** · NA · WITHDRAWN · sponsor: **Fertilys**

## Conditions studied

- Infertility, Female

## Interventions

- **PROCEDURE:** Intrauterine administration of hCG-activated peripheral blood mononuclear cells

## Key facts

- **NCT ID:** NCT04753736
- **Lead sponsor:** Fertilys
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2021-09-24
- **Primary completion:** 2021-11-01
- **Final completion:** 2021-11-01
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** lack of staff
- **Last updated:** 2023-09-18

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04753736

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04753736, "Immunophenotypage of RIF and RM Patients and Intrauterine Administration of PBMC". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT04753736. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*